Literature DB >> 15169919

Docking-dependent regulation of the Rb tumor suppressor protein by Cdk4.

Maura Wallace1, Kathryn L Ball.   

Abstract

Phosphorylation of target proteins by cyclin D1-Cdk4 requires both substrate docking and kinase activity. In addition to the ability of cyclin D1-Cdk4 to catalyze the phosphorylation of consensus sites within the primary amino acid sequence of a substrate, maximum catalytic activity requires the enzyme complex to anchor at a site remote from the phospho-acceptor site. A novel Cdk4 docking motif has been defined within a stretch of 19 amino acids from the C-terminal domain of the Rb protein that are essential for Cdk4 binding. Mutation or deletion of the docking motif prevents Cdk4-dependent phosphorylation of full-length Rb protein or C-terminal Rb fragments in vitro and in cells, while a peptide encompassing the Cdk4 docking motif specifically inhibits Cdk4-dependent phosphorylation of Rb. Cyclin D1-Cdk4 can overcome the growth-suppressive activity of Rb in both cell cycle progression and colony formation assays; however, while mutants of Rb in which the Cdk4 docking site has been either deleted or mutated retain growth suppressor activity, they are resistant to inactivation by cyclin D1-Cdk4. Finally, binding of Cdk4 to its docking site can inhibit cleavage of exogenous and endogenous Rb in response to distinct apoptotic signals. The Cdk4 docking motif in Rb gives insight into the mechanism by which enzyme specificity is ensured and highlights a role for Cdk4 docking in maintaining the Rb protein in a form that favors cell survival rather than apoptosis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15169919      PMCID: PMC419867          DOI: 10.1128/MCB.24.12.5606-5619.2004

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  64 in total

1.  G1 cyclins control the retinoblastoma gene product growth regulation activity via upstream mechanisms.

Authors:  L E Horton; Y Qian; D J Templeton
Journal:  Cell Growth Differ       Date:  1995-04

2.  Inhibition of G1-phase arrest induced by ionizing radiation in hematopoietic cells by overexpression of genes involved in the G1/S-phase transition.

Authors:  M Epperly; L Berry; A Halloran; J S Greenberger
Journal:  Radiat Res       Date:  1995-09       Impact factor: 2.841

3.  Use of an oriented peptide library to determine the optimal substrates of protein kinases.

Authors:  Z Songyang; S Blechner; N Hoagland; M F Hoekstra; H Piwnica-Worms; L C Cantley
Journal:  Curr Biol       Date:  1994-11-01       Impact factor: 10.834

4.  Negative regulation of the growth-promoting transcription factor E2F-1 by a stably bound cyclin A-dependent protein kinase.

Authors:  W Krek; M E Ewen; S Shirodkar; Z Arany; W G Kaelin; D M Livingston
Journal:  Cell       Date:  1994-07-15       Impact factor: 41.582

5.  Cyclin A/CDK2 binds directly to E2F-1 and inhibits the DNA-binding activity of E2F-1/DP-1 by phosphorylation.

Authors:  M Xu; K A Sheppard; C Y Peng; A S Yee; H Piwnica-Worms
Journal:  Mol Cell Biol       Date:  1994-12       Impact factor: 4.272

6.  A predictive scale for evaluating cyclin-dependent kinase substrates. A comparison of p34cdc2 and p33cdk2.

Authors:  J K Holmes; M J Solomon
Journal:  J Biol Chem       Date:  1996-10-11       Impact factor: 5.157

7.  Failure to dephosphorylate retinoblastoma protein in drug-resistant cells.

Authors:  Q P Dou; V W Lui
Journal:  Cancer Res       Date:  1995-11-15       Impact factor: 12.701

8.  A p16INK4a-insensitive CDK4 mutant targeted by cytolytic T lymphocytes in a human melanoma.

Authors:  T Wölfel; M Hauer; J Schneider; M Serrano; C Wölfel; E Klehmann-Hieb; E De Plaen; T Hankeln; K H Meyer zum Büschenfelde; D Beach
Journal:  Science       Date:  1995-09-01       Impact factor: 47.728

9.  Role of pRb-related proteins in simian virus 40 large-T-antigen-mediated transformation.

Authors:  J Zalvide; J A DeCaprio
Journal:  Mol Cell Biol       Date:  1995-10       Impact factor: 4.272

10.  p107 uses a p21CIP1-related domain to bind cyclin/cdk2 and regulate interactions with E2F.

Authors:  L Zhu; E Harlow; B D Dynlacht
Journal:  Genes Dev       Date:  1995-07-15       Impact factor: 11.361

View more
  10 in total

1.  Crystal structure of human CDK4 in complex with a D-type cyclin.

Authors:  Philip J Day; Anne Cleasby; Ian J Tickle; Marc O'Reilly; Joe E Coyle; Finn P Holding; Rachel L McMenamin; Jeff Yon; Rajiv Chopra; Christoph Lengauer; Harren Jhoti
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-23       Impact factor: 11.205

Review 2.  The other side of the coin: the tumor-suppressive aspect of oncogenes and the oncogenic aspect of tumor-suppressive genes, such as those along the CCND-CDK4/6-RB axis.

Authors:  Xiaomin Lou; Ju Zhang; Siqi Liu; Ningzhi Xu; D Joshua Liao
Journal:  Cell Cycle       Date:  2014-05-05       Impact factor: 4.534

3.  Cyclin D-Cdk4,6 Drives Cell-Cycle Progression via the Retinoblastoma Protein's C-Terminal Helix.

Authors:  Benjamin R Topacio; Evgeny Zatulovskiy; Sandra Cristea; Shicong Xie; Carrie S Tambo; Seth M Rubin; Julien Sage; Mardo Kõivomägi; Jan M Skotheim
Journal:  Mol Cell       Date:  2019-04-11       Impact factor: 17.970

4.  Angiotensin II regulates activation of Bim via Rb/E2F1 during apoptosis: involvement of interaction between AMPKβ1/2 and Cdk4.

Authors:  Yong-Chul Kim; Regina M Day
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2012-06-01       Impact factor: 5.464

Review 5.  Therapeutic potential of CDK4/6 inhibitors in renal cell carcinoma.

Authors:  Rebecca A Sager; Sarah J Backe; Elham Ahanin; Garrett Smith; Imad Nsouli; Mark R Woodford; Gennady Bratslavsky; Dimitra Bourboulia; Mehdi Mollapour
Journal:  Nat Rev Urol       Date:  2022-03-09       Impact factor: 16.430

6.  Suppression of activation of signal transducer and activator of transcription-5B signaling in the vessel wall reduces balloon injury-induced neointima formation.

Authors:  Venkatesh Kundumani-Sridharan; Dong Wang; Manjula Karpurapu; Zhimin Liu; Chunxiang Zhang; Nagadhara Dronadula; Gadiparthi N Rao
Journal:  Am J Pathol       Date:  2007-09-06       Impact factor: 4.307

7.  p27Kip1 inhibits cyclin D-cyclin-dependent kinase 4 by two independent modes.

Authors:  Arpita Ray; Melissa K James; Stéphane Larochelle; Robert P Fisher; Stacy W Blain
Journal:  Mol Cell Biol       Date:  2008-12-15       Impact factor: 5.069

8.  Structure-function analysis of the retinoblastoma tumor suppressor protein - is the whole a sum of its parts?

Authors:  Frederick A Dick
Journal:  Cell Div       Date:  2007-09-13       Impact factor: 5.130

9.  Cyclin-dependent kinase 2 (CDK2) is a key mediator for EGF-induced cell transformation mediated through the ELK4/c-Fos signaling pathway.

Authors:  C Peng; W Zeng; J Su; Y Kuang; Y He; S Zhao; J Zhang; W Ma; A M Bode; Z Dong; X Chen
Journal:  Oncogene       Date:  2015-06-01       Impact factor: 9.867

10.  Stress-mediated exit to quiescence restricted by increasing persistence in CDK4/6 activation.

Authors:  Hee Won Yang; Steven D Cappell; Ariel Jaimovich; Chad Liu; Mingyu Chung; Leighton H Daigh; Lindsey R Pack; Yilin Fan; Sergi Regot; Markus Covert; Tobias Meyer
Journal:  Elife       Date:  2020-04-07       Impact factor: 8.140

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.